Corporate Responsibility Report

Overview

The report describes Royalty Pharma's materiality assessment and Board-led sustainability oversight, alongside a new Senior Leadership Committee and DEI Task Force. The company reports 89 employees and 49% female workforce representation for 2023. Environmental disclosures report 32,002 MT CO2e from Scope 3 Category 15 investments, while Scope 1 and Scope 2 are reported as N/A because the company is externally managed. Apex Companies, LLC independently verified the Scope 3 investment emissions to a limited assurance level.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 25 April 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services